Stockscreener 앱 받기
215.13
4.49%
9.25
시장 영업 전:
216.05
0.92
+0.43%
전일 마감가:
$205.88
열려 있는:
$208.06
하루 거래량:
1.52M
Relative Volume:
1.50
시가총액:
$15.36B
수익:
$2.88B
순이익/손실:
$499.60M
주가수익비율:
31.92
EPS:
6.74
순현금흐름:
$321.60M
1주 성능:
+1.24%
1개월 성능:
-5.93%
6개월 성능:
-24.88%
1년 성능:
-42.69%
1일 변동 폭
$207.25
$216.98
1주일 범위
$193.05
$216.98
52주 변동 폭
$187.43
$394.42
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
215.13 | 15.36B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
478.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
199.88 | 57.39B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
93.31 | 45.22B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
214.08 | 31.43B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.79 | 15.89B | 3.90B | 392.30M | 288.10M | 1.95 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
Ready to Jump After Recent Trade: West Pharmaceutical Services, Inc (WST) - Sete News
Examining the Potential Price Growth of West Pharmaceutical Services, Inc (WST) - knoxdaily.com
Milestone Pharmaceuticals Inc [MIST] Investment Guide: What You Need to Know - knoxdaily.com
Will Segmental Performance Drive West Pharmaceutical's Q1 Earnings? - Nasdaq
Press Release Distribution & PR Platform - ACCESS Newswire
West Pharmaceutical Services, Inc. (WST): One of the Low Profile Dividend Champions to Buy - Yahoo
Earnings Preview: West Pharmaceutical Services (WST) Q1 Earnings Expected to Decline - Yahoo Finance
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
West Pharmaceutical Services (WST) Expected to Announce Earnings on Thursday - Defense World
West to Host Second-Quarter 2024 Conference Call - Quantisnow
Agree To Purchase West Pharmaceutical Services At $180, Earn 11.2% Annualized Using Options - Nasdaq
Fill Finish Manufacturing Market to Witness Upsurge in Growth - openPR.com
West Pharmaceutical price target lowered to $280 from $285 at BofA - Yahoo Finance
UGI Corporation to Announce Q2 2025 Results with Live Webcast - MyChesCo
West Pharmaceutical Announces Departure of Senior Executive - TipRanks
BofA Securities Cuts West Pharmaceutical Services Price Target to $280 From $285, Maintains Neutral Rating - marketscreener.com
West Pharmaceutical Services to Announce Q1 2025 Results with Live Webcast and Q&A Session - MSN
Zacks Research Issues Positive Outlook for WST Earnings - Defense World
Wellington Management Group LLP Buys 99 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services Earnings Preview: What to Expect - MSN
West Pharmaceutical Services, Inc.'s (NYSE:WST) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Zacks Research Analysts Reduce Earnings Estimates for WST - Defense World
Penn College lab named in honor of West Pharmaceutical Services - Penn State University
College lab named in honor of West Pharmaceutical Services - Pennsylvania College of Technology
WST ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of West Pharmaceutical Services, Inc. Shareholders Who Lost Money - ACCESS Newswire
The Latest Breaking News on West Pharmaceutical Services Earnings Preview: What to Expect - inkl
West Pharmaceutical Services Earnings Preview: What To Expect - Barchart.com
West to Host First-Quarter 2025 Conference Call - The Malaysian Reserve
Mark Your Calendar: West Pharmaceutical Announces Critical Q1 2025 Earnings Date - Stock Titan
Will Weakness in West Pharmaceutical Services, Inc.'s (NYSE:WST) Stock Prove Temporary Given Strong Fundamentals? - simplywall.st
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsWST - ACCESS Newswire
West Pharmaceutical stock hits 52-week low at $196.78 - Investing.com Australia
West Pharmaceutical stock hits 52-week low at $196.78 By Investing.com - Investing.com India
Analysis of China-to-West pharmaceutical licensing deals in 2024 - Nature
ATTENTION WST SHAREHOLDERS: Investors who Lost Money on West Pharmaceutical Services, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - ACCESS Newswire
Trump administration shutters DC foreign policy think tank Wilson Center - MarketScreener
Teacher Retirement System of Texas Takes Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsWST - ACCESS Newswire
National Wealth Management Group LLC Makes New $706,000 Investment in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Pharmaceutical Testing Services Market Set to Witness - openPR.com
Delcath Systems (NASDAQ:DCTH) and West Pharmaceutical Services (NYSE:WST) Critical Survey - Defense World
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment - ACCESS Newswire
Commonwealth Equity Services LLC Trims Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
How Is The Market Feeling About West Pharmaceutical Servs? - Benzinga
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks - Yahoo Finance
West Pharmaceutical Services, Inc. (NYSE:WST) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
West Pharmaceutical Services: Bylaw Changes and Share Price Dynamics - AInvest
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.39%
자본화:
|
볼륨(24시간):